Skip to main content

Spectral Medical Inc(EDT-T)
TSX

Today's Change
Real-Time Last Update

Closing Bell: Spectral Medical Inc up on Friday (EDT)

Automated Summaries - The Globe and Mail - Fri Apr 5, 4:02PM CDT

In today's trading, shares of Spectral Medical Inc opened at $0.42 and closed at $0.45. It traded at a low of $0.41 to a high of $0.45.

The price raised 9.76% from the previous day's close of $0.41.

During the day across North America, the TSX Composite closed -0.27% at 22051.79, the S&P 500 closed -1.23% at 5147.21, the Dow Jones Industrial Average closed -1.35% at 38596.98 and the Nasdaq Composite closed -1.40% at 16049.08.

Spectral Medical Inc traded under EDT on the Toronto Stock Exchange (TSX).

Trading volume was 82,262 on 105 total trades, while having an average volume of 66,836 over the last 5-days.

Trading across the entire TSX saw 2,800 price advancers against 2,386 declines and 147 unchanged.

During the prior 52 weeks, EDT.TO has traded as high as $0.67 (February 07,2024) and low as $0.23 (June 14,2023). Moreover, the shares have soared 40.63 percent in the last year, while they have boosted 5.88% this year.

It announced a 0.12 dividend on November 29/11, with an December 19/11 ex-date and January 20/12 pay day.

Following today's trading, Spectral Medical Inc has a market capitalization of $114.22 million on a float of 278,576 shares outstanding. Its annual EPS is $-0.06.

Spectral Medical Inc is a None company headquartered in Toronto, CAN.

Currently, Spectral Medical Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe

inside the market
Short sales on the TSX: What bearish investors are betting against
Larry MacDonald